BazEkon - Biblioteka Główna Uniwersytetu Ekonomicznego w Krakowie

BazEkon home page

Meny główne

Autor
Koperny Magdalena (Wojewódzka Stacja Sanitarno-Epidemiologiczna w Krakowie), Kargul Agnieszka (Wojewódzka Stacja Sanitarno-Epidemiologiczna w Krakowie), Seweryn Michał (Uniwersytet Jagielloński Collegium Medicum), Niżankowski Rafał (Uniwersytet Jagielloński Collegium Medicum)
Tytuł
The Prevalence of Combination Vaccines for Children in Europe. Analysis of the Availability and Funding
Źródło
Journal of Health Policy and Outcomes Research, 2013, nr 2, s. 18-31, rys., tab., bibliogr. 14 poz.
Słowa kluczowe
Finansowanie ochrony zdrowia, Ochrona zdrowia, Profilaktyka zdrowotna, Choroby
Health care financing, Health care protection, Preventive health care, Illness
Uwagi
summ.
Abstrakt
The article presents an analysis of data from 33 European countries on combination vaccines against diphtheria (D), tetanus (T), pertussis (P), polio (IPV), Haemophilus influenzae type b (Hib), hepatitis B (HBV). The purpose of this article is to present the availability and funding mechanisms of vaccinations which represent pharmacological innovations. The performed analysis included 5 approved combination vaccines marketed in Europe (5-in-1 DTaP-IPV-Hib vaccines, and 6-in-1 DTaP-IPV-Hib-HepB vaccines). Although in the vast majority of countries the analysed vaccinations are not mandatory, the vaccination rate remains very high. Significant differences between the European countries can be seen in vaccination schedules or the types of available combination vaccines in the national childhood immunisation programmes. Despite the different rules and regulations regarding the funding of combination vaccinations from public resources, countries systematically seek to provide patients with the latest generation formulations.(original abstract)
Pełny tekst
Pokaż
Bibliografia
Pokaż
  1. Annual epidemiological report. Reporting on 2010 surveillance data and 2011 epidemic intelligence data 2012, ECDC
  2. Summary of Recommendations for Child/Teen Immunization (Age birth through 18 years). Available from: http://www.immunize.org/catg.d/p2010.pdf; [Accessed: 5.08.2013]
  3. Summary of WHO Position Papers - Recommended Routine Immunizations for Children. Available from: http://www.who.int/immunization/policy/Immunization_routine_table2.pdf; [Accessed: 5.08.2013]
  4. Summary of the European public assessment report (EPAR) for Infanrix Hexa. Available from: http://www.ema.europa.eu/docs/pl_PL/document_library/EPAR__Product_Information/human/000296/WC550003250.pdf; [Accessed: 5.08.3013]
  5. Infanrix penta 24 June 2010 EMA/378903/2013 Committee for Medicinal Products for Human Use (CHMP). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000295/WC500148294.pdf; [Accessed: 19.09.3013]
  6. Summary of the European public assessment report (EPAR) for Hexacima. Available from: http://www.ema.europa.eu/docs/pl_PL/document_library/EPAR__Summary_for_the_public/human/002702/WC500145811.pdf; [Accessed: 5.08.3013]
  7. http://www.urpl.gov.pl/system/drugs/dki/charakterystyka/2011-10-05_chpl_pentaxim_pkt_6_5_wersja_ostateczna.pdf; [Accessed: 19.09.3013]
  8. Available from: http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con108611.pdf; [Accessed: 6.08.3013]
  9. Available from: http://www.ssi.dk/English/Vaccines/Bulk Vaccines and Toxoids.aspx; [Accessed: 6.08.3013]
  10. Wilsdon T., Serota A. A comparative analysis of the role and impact of Health Technology Assessment. CRA Charles River Associates Project No. D15891-00
  11. WHO Vaccine Preventable Diseases Monitoring System. Available from: http://apps.who.int/immunization_monitoring/globalsummary/; [Accessed: 6.08.3013]
  12. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html; [Accessed: 19.09.3013]
  13. Available from: http://www.quandl.com/health/dtp3-all-countries; [Accessed: 19.09.3013]
  14. Szczepienia ochronne w Polsce w 2012 roku. Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny - Zakład Epidemiologii Główny Inspektorat Sanitarny - Departament Zapobiegania i Zwalczania Zakażeń i Chorób Zakaźnych u Ludzi. [Wstępne dane. 15.06.2013]
Cytowane przez
Pokaż
ISSN
2299-1247
Język
eng
URI / DOI
http://dx.doi.org/10.7365/JHPOR.2013.4.3
Udostępnij na Facebooku Udostępnij na Twitterze Udostępnij na Google+ Udostępnij na Pinterest Udostępnij na LinkedIn Wyślij znajomemu